It also inhibits microglial activation in the brain and spinal cord, reducing production of reactive oxygen species and potentially neuroexcitatory chemicals
doi: 10.1590/S0100-879X2004001100003 49 HenricksPAJNijkampFP
Unlike many other weight loss therapies, tirzepatide targets both GLP-1 and GIP receptors, enhancing its effectiveness in reducing appetite and increasing satiety
AOD-9604 directly targets fat tissue without affecting GH/IGF-1 axis, making it a more selective option for pure fat metabolism enhancement without hormonal changes
Weight loss can trigger your bodys stress response: The hypothalamic-pituitary-adrenal (HPA) axis, which is your bodys stress-response system, can be activated by significant weight loss
About Total in Body: The gray bars are a simplified estimate based on each medications published half-life, not an exact pharmacokinetic measurement